Condition
Steroid-Induced Diabetes
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Enrolling By Invitation2
Unknown1
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07190378Enrolling By InvitationPrimary
Predictive Factors and Monitoring Strategies in Steroid-Induced Diabetes
NCT07117240Phase 4Enrolling By InvitationPrimary
Evaluation of the Efficacy and Safety of GLP-1 Receptor Agonist Therapy In Steroid-Induced Diabetes
NCT06318442Not ApplicableRecruitingPrimary
The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes
NCT05843019Unknown
Adherence in Global Airways - Steroid Intake and Effects on Chronic Rhinosinosinutis
Showing all 4 trials